[Federal Register Volume 78, Number 35 (Thursday, February 21, 2013)]
[Notices]
[Page 12103]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-03895]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; GE 
Healthcare

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on August 31, 2012, GE 
Healthcare, 3350 North Ridge Avenue, Arlington Heights, Illinois 60004-
1412, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of Cocaine 
(9041), a basic class of controlled substance listed in schedule II.
    The company plans to manufacture a radioactive product to diagnose 
Parkinson's disease; and to manufacture a bulk investigational new drug 
(IND) for clinical trials.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such a substance, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than April 22, 2013.

    Dated: February 8, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-03895 Filed 2-20-13; 8:45 am]
BILLING CODE 4410-09-P